Transcatheter Aortic Valve Replacement News and Research

RSS

MHIF creates scientific program to address gaps in treating valvular heart disease patients

Despite significant medical advances, there continue to be significant gaps in the health care of the growing number of patients with valvular heart disease. In the USA, the total number of people aged 65 years or older with valvular heart disease will grow to approximately 5.2 million by year 2020, and 6.8 million individuals by the year 2030. The Minneapolis Heart Institute Foundation- has created a scientific program, "Valve Summit 2014: The Science and Delivery of Optimal, Multi-Disciplinary Care," to address the ongoing, complex evolution in the clinical management of patients with valvular heart disease. The conference will be held on April 25th and 26th at the Radisson Blu in downtown Minneapolis.

4 Dec 2013

AATS, cardiovascular professional societies release overview of transcatheter therapies for mitral regurgitation

AATS and three cardiovascular professional societies today released an overview of transcatheter therapies for mitral regurgitation.

26 Nov 2013

Aortic valve replacement improves survival and outcomes in elderly patients

Jose Augusto Barreto-Filho, M.D., Ph.D., of the Federal University of Sergipe and the Clinica e Hospital Sao Lucas, Sergipe, Brazil, and colleagues assessed procedure rates and outcomes of surgical aortic valve replacement (AVR) among 82,755,924 Medicare fee-for-service beneficiaries between 1999 and 2011.

19 Nov 2013

Current percutaneous techniques shed light on treatment of heart valve leakage

A Paravalvular regurgitation, or leakage, commonly affects valvular prostheses, particularly artificial valves placed percutaneously according to data presented at the 2013 Transcatheter Cardiovascular Therapeutics (TCT) conference.

4 Nov 2013

Bluhm Institute enrolls first patient in SALUS trial to evaluate movable, non-metallic heart valve

Northwestern's Bluhm Cardiovascular Institute has enrolled its first participant in SALUS, a clinical trial studying the effectiveness of a prosthetic aortic heart valve that can be placed without open-heart surgery.

10 Oct 2013

CRF to present groundbreaking clinical trial findings at TCT 2013 scientific symposium

The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at next month's Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium.

21 Sep 2013

Boston Scientific announces positive results from REPRISE II clinical trial of Lotus Valve System

Boston Scientific Corporation reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the safety and performance of the Lotus™ Valve System in symptomatic patients with severe aortic stenosis considered at high risk for surgical valve replacement.

17 Sep 2013

Doctors create new route to implant artificial heart valve

Doctors at Henry Ford Hospital have created a new route to the heart to implant an artificial heart valve by temporarily connecting major blood vessels that do not normally intersect.

14 Aug 2013

Study may allow more patients to benefit from transcatheter aortic valve replacement

The Society of Thoracic Surgeons (STS) has launched an investigational study with the American College of Cardiology (ACC) that may allow more patients to benefit from transcatheter aortic valve replacement (TAVR), a minimally invasive procedure that delivers a replacement heart valve via a catheter.

18 Jul 2013

New treatment option for patients with aortic stenosis

Robert Stoler, MD, FACC, FSCAI, director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital and co-medical director, Division of Cardiology, is leading Baylor's participation in an exciting clinical trial to research a new treatment option for AS patients.

From Medtronic 21 Jun 2013

REPRISE II trial: Lotus Valve System meets primary endpoint in severe aortic valve disease patients

Boston Scientific Corporation reports positive results from a pre-specified analysis of the first 60 patients enrolled in the REPRISE II trial evaluating the performance and safety of the Lotus™ Valve System in symptomatic patients with severe aortic valve disease considered at high risk for surgical valve replacement.

23 May 2013

Society of Thoracic Surgeons releases aortic valve, ascending aorta clinical practice guidelines

The Society of Thoracic Surgeons has released a set of clinical practice guidelines to address major advances in the evaluation and management of patients with aortic valve disease.

1 Apr 2013

Catheter-delivered aortic valve durable at three years

All-cause and cardiovascular mortality were similar for transaortic valve replacement compared to open-heart surgery in high-risk older patients at three years with no increased risk of stroke after 30 days, according to results from the PARTNER study presented today at the American College of Cardiology's 62nd Annual Scientific Session.

13 Mar 2013

New Sapien XT aortic valve reduces rate of death and strokes

The new Sapien XT aortic valve showed a non-significantly lower rate of death and strokes at 30 days than the original model, and both valves demonstrated notably better short-term outcomes than seen with the Sapien system in PARTNER I, according to the first results from the PARTNER II study presented today at the American College of Cardiology's 62nd Annual Scientific Session.

12 Mar 2013

FDA grants IDE approval to STS and ACC to study alternative access approaches for TAVR

The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) have received a unique investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to study "alternative access" approaches for transcatheter aortic valve replacement (TAVR) using the STS/ACC TVT Registry.

14 Feb 2013

New heart valve procedure saves life of 94-year old with aortic stenosis

94-year old Santa Monica resident Vivian Valentine has much to be thankful for this Thanksgiving. A new life-saving heart valve procedure done without traditional open heart surgery has given her a new lease on life.

20 Nov 2012

St. Luke's unveils Discovery IGS 730 Hybrid OR from GE Healthcare

St. Luke's University Hospital unveiled the Discovery IGS 730 Hybrid OR from GE Healthcare today, becoming the first hospital in the United States to offer this exciting new technology.

17 Nov 2012

TAVR procedure yields lower mortality rates for patients with aortic stenosis after three years

A study found that transcatheter aortic valve replacement (TAVR) yielded lower mortality rates after three years compared with medical therapy in patients deemed to be ineligible for conventional aortic valve surgery.

25 Oct 2012

MID commences treatment in Permaseal cardiac access and closure technology clinical trial

Micro Interventional Devices, Inc., an emerging cardiovascular medical device company, announced today that the first patient has been treated using its self-sealing, cardiac access and closure technology, Permaseal. The patient is the first to be enrolled in the company's STASIS clinical trial that has commenced in Europe.

22 Oct 2012

Morton Plant first hospital in the Tampa Bay area to perform transapical TAVR

Morton Plant Hospital is the first hospital in the Tampa Bay area to perform Transcatheter Aortic Valve Replacement (TAVR) by the transapical approach. Transapical TAVR is the latest FDA-approved treatment for people suffering from severe aortic stenosis.

20 Oct 2012